Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery-Reference-Cited by-同舟云学术

Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery

Published:2017-07-01 Issue:7 Volume:152 Page:665
ISSN:2168-6254
Container-title:JAMA Surgery
language:en
Short-container-title:JAMA Surg

Author:

Tadros Audree B.¹,Yang Wei T.²,Krishnamurthy Savitri³,Rauch Gaiane M.²,Smith Benjamin D.⁴,Valero Vicente⁵,Black Dalliah M.¹,Lucci Anthony¹,Caudle Abigail S.¹,DeSnyder Sarah M.¹,Teshome Mediget¹,Barcenas Carlos H.⁵,Miggins Makesha¹,Adrada Beatriz E.²,Moseley Tanya²,Hwang Rosa F.¹,Hunt Kelly K.¹,Kuerer Henry M.¹

Affiliation:

1. Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston

2. Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston

3. Department of Pathology, University of Texas MD Anderson Cancer Center, Houston

4. Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston

5. Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston

Publisher

American Medical Association (AMA)

Subject

Surgery

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Top Ten Annals of Surgical Oncology Original Articles on Twitter/X: 2020–2023;Annals of Surgical Oncology;2024-08-13

2. Axillary surgical staging after neoadjuvant chemotherapy: does technical accuracy matter?;Gland Surgery;2024-08

3. The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast Cancer;Annals of Surgical Oncology;2024-07-24

4. Efficacy and prognosis of HER2-Low and HER2-Zero in triple-negative breast cancer after neoadjuvant chemotherapy;Scientific Reports;2024-07-23

5. Utility of Axillary Staging in Older Patients with HER2-Positive Breast Cancer;Annals of Surgical Oncology;2024-07-16